Targeting Rare Diseases
AOP Orphan is a European pioneer in the development, production and marketing of treatments for people with rare diseases also known as orphan diseases.
“Being a part of AOP Orphan, a company whose priority is to help patients with rare diseases, is very motivating. It is gratifying to work in the team of experienced colleagues for the benefit of patients”
Facts & Figures
AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialization of drugs for more than 20 years already.
Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Slovak health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases.
Slovakia occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 2006. AOP Orphan Slovakia is a team of around five employees in the Marketing & Sales, and Medical for all three therapeutic divisions.
Vision & Mission
